How to prevent VTE in COVID-19 patients?: Chinese & European perspectives

Chen Xiangqi (Fujian, China), Niki Ubags (Lausanne, CH), Sheila Ramjug (Manchester, United Kingdom)

Source: ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives
Number: 0

Webcast

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Chen Xiangqi (Fujian, China), Niki Ubags (Lausanne, CH), Sheila Ramjug (Manchester, United Kingdom). How to prevent VTE in COVID-19 patients?: Chinese & European perspectives. ERS webinar 2020: How to prevent VTE in COVID-19 patients?: Chinese & European perspectives

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

Paul Thomas - 04.07.2020 18:15
Absolute excellent lecture

Paul Thomas - 04.07.2020 18:15
Absolute excellent lecture

Khalid Hassan Ba-Msahell - 26.06.2020 00:59
Thanks
You must Login to comment this presentation.


Related content which might interest you:
Venous thromboembolic (VTE) in patients with ALS: an incidence study
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021


Occult cancer in patients with acute venous thromboembolism: Why, when and where to investigate
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

Prophylaxis of venous thromboembolism : what is new?
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019


Tinzaparin and vitamin K antagonist (VKA) use in patients with cancer associated venous thromboembolism (VTE): A cohort study
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Venous thromboembolism prophylaxis in hospitals in China: a nationwide survey
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020


Compliance with venous thromboembolic (VTE) risk assessment and prophylaxis in medical inpatients at an English DGH
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010

Thrombophilias in 60 Bulgarian patients with "idiopathic" venous thromboembolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012

Recurrence patterns for venous thromboembolism - who is most at risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

Venous thromboembolism prophylaxis in hospitalised patients with pneumonia: a prospective survey
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Venous thromboembolism in patients immobilized at home
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015


Treatment of venous thromboembolism in cancer patients with tinzaparin beyond 6 months. TiCAT study
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016

The diagnosis of malignancy following a venous thromboembolic event - how high is the risk?
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014

Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review
Source: Eur Respir J 2015; 45: 201-210
Year: 2015



Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002

Venous thromboembolism (VTE) prophylaxis in acute medical admissions to a university hospital
Source: Annual Congress 2009 - Pulmonary embolism and cardiovascular diseases
Year: 2009


Factors that predict the risk of recurrent venous thromboembolism (VTE) in patients with VTE and factor V Leiden (FVL)
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010

Age is a major risk factor of venous thromboembolism (VTE)
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer.
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Search predictive factors of recurrence in venous thromboembolic disease associated with cancer after withdrawal of the anticoagulation. HISPALIS study
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016

Venous thromboembolism and pulmonary cancer: A ten years series
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010